Who are DEM BioPharma's investors?

DEM BioPharma's investors include Alta Partners, Astellas Venture Management LLC, DC Investment Partners, Longwood Fund, Pfizer Venture Investments, UTokyo Innovation Platform Co. Ltd., Insight Partners, Pfizer Ventures.

Where is DEM BioPharma headquartered?

DEM BioPharma is headquartered in Cambridge, US.

DEM BioPharma

Cambridge, US · 8 known investors

dembiopharma.com ↗

DemBiopharma is a biopharmaceutical company based in Cambridge, Massachusetts.

Biotech

Investors · 8

Alta PartnersJackson · $1M – $12M

Astellas Venture Management LLCSouth San Francisco · $200K – $5M

DC Investment PartnersMcLean · $10M

Longwood FundBoston

Pfizer Venture Investments$5M – $20M

UTokyo Innovation Platform Co. Ltd.Tokyo

Insight PartnersreportedNew York · $120M – $350M

Pfizer Venturesreported

In the news

Sell or Invest in DEM BioPharma Stock Pre-IPOnasdaqprivatemarket.com · Jun 2025

User | thepilotnews.com - DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSObusiness.thepilotnews.com · Sep 2022

DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO - BioSpacebiospace.com · Sep 2022

Pfizer-Backed DEM Bio Launches to Leverage CRISPR in Immuno-Oncology - BioSpacebiospace.com · Jun 2022

DEM BioPharma Launches with $70 Million Financing - BioSpacebiospace.com · Jun 2022

Frequently asked questions

What does DEM BioPharma do?: DemBiopharma is a biopharmaceutical company based in Cambridge, Massachusetts.
Who are DEM BioPharma's investors?: DEM BioPharma's investors include Alta Partners, Astellas Venture Management LLC, DC Investment Partners, Longwood Fund, Pfizer Venture Investments, UTokyo Innovation Platform Co. Ltd., Insight Partners, Pfizer Ventures.
Where is DEM BioPharma headquartered?: DEM BioPharma is headquartered in Cambridge, US.